Wordt geladen...
Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes
BACKGROUND: Patient-reported measures can be used to examine whether drug differences other than clinical efficacy have an impact on outcomes that may be important to patients. Although exenatide and insulin glargine appear to have similar efficacy for treatment of type 2 diabetes, there are several...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2006
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1634743/ https://ncbi.nlm.nih.gov/pubmed/17034640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7525-4-80 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|